Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New magnetic catheter aims to give control back to men with urinary retention

NCT ID NCT05848037

Symptom relief Sponsor: Ingenion Medical Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early This study
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new type of catheter for men who need long-term catheters due to urinary retention. The CymActive catheter has a magnetic valve that lets users control when they urinate, unlike standard catheters that drain continuously. The study aimed to see if it was more comfortable and improved quality of life compared to standard Foley catheters, but it was terminated early with only 6 participants.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
CymActive catheter device (a magnetically controlled catheter)
What this could lead to
If it works, this could offer a more comfortable and dignified option for men who need long-term catheters.
What could go wrong
This was a very small, early study that was terminated, so results are limited. The device may not be better than standard catheters and could have similar risks like infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

6 people

The number who actually took part.

Started

May 2025

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Participants will be eligible to enrol in the study only if all of the following apply * Male (anatomical) * Adult, more than or equal to 18 years of age * Capacity to give written informed consent * Documented urinary retention, this may include patients who await a TURP, or similar, procedure * Non-neurogenic urinary retention * Catheter use on a long-term basis (\>4 weeks) Exclusion Criteria: Participants will not be eligible to enrol in the study if any of the following apply * Symptomatic bacteriuria (at screening) * Surgical procedures performed in the lower urinary tract * Neurogenic urinary retention * Patients who have had a TURP (or similar) procedure * Any malignancy in active/radical treatment (note: subjects with prostate or bladder cancer under surveillance only, may be enrolled into the study, at the Investigator's discretion) * Patients who have a pacemaker or significant cardiovascular disease * Participants with any contraindications, as outlined in the IFU * Active participation in another interventional trial within the last 30 days * Any condition, abnormality or issue, for which the investigator assesses the subject as unsuitable for an interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Non-neurogenic urinary retention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hinman syndrome Urinary Retention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Urinary retention

Contacts and locations

Locations

  • Addenbrookes Hospital - Cambridge University Hospitals NHS Foundation Trust

    Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom

  • Frimley Park Hospital - Frimley Health NHS Foundation Trust

    Camberley, Surrey, GU16 7UJ, United Kingdom

  • Ipswich Hospital - East Suffolk and North Essex NHS Foundation Trust

    Ipswich, Essex, IP4 5PD, United Kingdom

  • Royal Devon & Exeter Hospital - Royal Devon University Healthcare NHS Trust

    Exeter, Devon, EX2 5DW, United Kingdom

  • Southmead Hospital - North Bristol NHS Trust,

    Bristol, BS10 5NB, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.